Trial
NCT03059563
Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Dopamine D2/3 Receptor Availability
Intervention
Varenicline
Why stopped
Global pandemic
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-08